Combination Therapy for Colorectal Cancer Shows Benefit Despite RAS Gene Mutations
Late line monoclonal antibody therapy for the treatment of metastatic colorectal cancer appears to be effective even in the presence of mutations in a proto-oncogene. Karl Landsteiner University of Health Sciences is an important study partner. Krems (Austria), 19. December, 2023: A recently approved combination therapy for the treatment of metastatic colorectal cancer appears to […]